WebJul 22, 2013 · MyPRS, developed by UAMS, has been marketed by Signal Genetics since 2011. The multi-gene test, performed on bone marrow aspirate material, has been incorporated into the routine management of patients diagnosed with Multiple Myeloma in numerous treatment centers across the country. WebFeb 2, 2015 · The use of MyPRS to aid in the selection of high-risk MM patients is critical to this trial. UAMS and Signal Genetics have reached a major accomplishment and believe that with the recent IND filing and receipt of a conditionally approved IDE for MyPRS, we have demonstrated to the FDA the potential benefits of our work for the MM patient population.
Signal Genetics LLC Announces Update to MyPRS™ Gene
WebNov 5, 2015 · Signal Genetics, Inc., headquartered in Carlsbad, California, is a commercial stage, molecular diagnostic company focused on providing innovative diagnostic services … WebSep 24, 2010 · Signal Genetics’ groundbreaking MyPRS™ genomic testing platform will be used to further a current research program of Array BioPharma in multiple myeloma. The … flexees comfort shapewear
PRS Gene - GeneCards PRS Genetic Locus
WebNov 1, 2016 · BOULDER, Colo. & CARLSBAD, Calif.--(BUSINESS WIRE)--Signal Genetics, Inc. (Nasdaq: SGNL) (“Signal”) and Miragen Therapeutics, Inc. (“miRagen”), a privately-held biopharmaceutical company, today announced that they have entered into a definitive merger agreement under which the stockholders of miRagen are currently estimated to … WebDec 2, 2016 · Methods: Reproducibility studies show that MyPRS results are less than 1% discordant starting from isolated plasma cells and return successful results in up to 95% … WebMay 27, 2011 · MyPRS is currently available nationally to community-based hematologists and medical oncologists through a similar arrangement with Caris Life Sciences." About Signal Genetics. Signal Genetics, the parent company of Myeloma Health and Respira Health, is a privately held predictive genetic testing company focused on helping cancer … flexees easy up brief